Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 34,105 | 28,429 | 25,086 | 34,699 | 29,449 |
| Operating Income | -34,105 | -28,429 | -25,086 | -34,699 | -29,449 |
| Interest Expense | 0 | 0 | 0 | 214 | 504 |
| Other Income | 3,828 | 3,855 | 4,087 | 4,064 | 1,330 |
| Pre-tax Income | -30,277 | -24,574 | -20,999 | -30,849 | -28,623 |
| Net Income Continuous | -30,277 | -24,574 | -20,999 | -30,849 | -28,623 |
| Net Income | $-30,277 | $-24,574 | $-20,999 | $-30,849 | $-28,623 |
| EPS Basic Total Ops | -0.55 | -0.46 | -0.40 | 6.23 | -1.46 |
| EPS Basic Continuous Ops | -0.69 | -0.58 | -0.50 | 5.54 | -1.91 |
| EPS Diluted Total Ops | -0.55 | -0.46 | -0.40 | 6.23 | -1.46 |
| EPS Diluted Continuous Ops | -0.69 | -0.58 | -0.50 | 5.54 | -1.91 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.46 | -0.40 | -0.49 | -1.46 |
| EBITDA(a) | $-35,125 | $-29,913 | $-26,867 | $-36,928 | $-29,469 |